| 000 | 015510000a22003490004500 | ||
|---|---|---|---|
| 003 | EG-GICUC | ||
| 005 | 20250223025256.0 | ||
| 008 | 060917s2006 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GICUC _beng _cEG-GICUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.08.01.Ph.D.2006.Sa.E | ||
| 100 | 0 | _aSahar Mohamed Abdelraouf | |
| 245 | 1 | 0 |
_aEvaluation study of some biochemical markers in malignant and premalignant liver diseases / _cSahar Mohamed Abdelraouf ; Supervised Maged M. A .Barakat , Wafaa H. El Metnawy , Mamdouh El Shirbiny Ramadan |
| 246 | 1 | 5 | _aدراسة تقيمية لبعض الدلالات البيوكيميائية لمراحل حدوث سرطان الكبد |
| 260 |
_aCairo : _bSahar Mohamed Abdelraouf , _c2006 |
||
| 300 |
_a152 P. : _bcharts ; _c30cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Biochemistry | ||
| 520 | _aHepatitis C virus (HCV) is the most common cause of chronic hepatitis in the worldApproximately 20 of patients with HCV will progress to chronic hepatitis , cirrhosis and hepatocellular carcinoma (HCC) over a period of 14 to 28 years | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAFP | |
| 653 | 4 | _aCirrhosis | |
| 653 | 4 | _aHCV | |
| 700 | 0 |
_aMaged M. A. Barakat , _eSupervisor |
|
| 700 | 0 |
_aMamdouh Elshirbiny Ramadan , _eSupervisor |
|
| 700 | 0 |
_aWafaa H. Elmetnawy , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aMustafa _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c9447 _d9447 |
||